BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19200257)

  • 1. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
    Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
    Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of MIA protein during melanoma cell migration.
    Schmidt J; Bosserhoff AK
    Int J Cancer; 2009 Oct; 125(7):1587-94. PubMed ID: 19521988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of integrin activity by MIA.
    Bauer R; Humphries M; Fässler R; Winklmeier A; Craig SE; Bosserhoff AK
    J Biol Chem; 2006 Apr; 281(17):11669-77. PubMed ID: 16517605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of MIA in melanocytes and early development of melanoma.
    Poser I; Tatzel J; Kuphal S; Bosserhoff AK
    Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
    Bosserhoff AK; Echtenacher B; Hein R; Buettner R
    Melanoma Res; 2001 Aug; 11(4):417-21. PubMed ID: 11479431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma.
    Bosserhoff AK; Ellmann L; Quast AS; Eberle J; Boyle GM; Kuphal S
    Mol Carcinog; 2014 Aug; 53(8):635-47. PubMed ID: 23625515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
    Kuphal S; Bosserhoff AK
    Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.
    Bosserhoff AK; Stoll R; Sleeman JP; Bataille F; Buettner R; Holak TA
    Lab Invest; 2003 Nov; 83(11):1583-94. PubMed ID: 14615412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional implication of truncated P-cadherin expression in malignant melanoma.
    Bauer R; Bosserhoff AK
    Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.
    de Vries TJ; Fourkour A; Punt CJ; Diepstra H; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(6):1066-70. PubMed ID: 10576666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
    Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between cadherins and α2β1 integrin differentially regulates melanoma cell invasion.
    Siret C; Terciolo C; Dobric A; Habib MC; Germain S; Bonnier R; Lombardo D; Rigot V; André F
    Br J Cancer; 2015 Nov; 113(10):1445-53. PubMed ID: 26512877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and functional role of CRIPTO-1 in cutaneous melanoma.
    De Luca A; Lamura L; Strizzi L; Roma C; D'Antonio A; Margaryan N; Pirozzi G; Hsu MY; Botti G; Mari E; Hendrix MJ; Salomon DS; Normanno N
    Br J Cancer; 2011 Sep; 105(7):1030-8. PubMed ID: 21863025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel cadherins expressed in human melanoma cells.
    Matsuyoshi N; Tanaka T; Toda K; Imamura S
    J Invest Dermatol; 1997 Jun; 108(6):908-13. PubMed ID: 9182820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.
    Bosserhoff AK
    Pigment Cell Res; 2005 Dec; 18(6):411-6. PubMed ID: 16280006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].
    Bosserhoff AK; Golob M; Buettner R; Landthaler M; Hein R
    Hautarzt; 1998 Oct; 49(10):762-9. PubMed ID: 9857251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.